TONIX PHARMACEUTICALS HOLDIN (TNXP) Stock Analyst Ratings
NASDAQ:TNXP - Nasdaq - US8902608392 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 83% to TNXP. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 62.9. This target is 40.65% above the current price.
TNXP was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about TNXP.
In the previous month the buy percentage consensus was at a similar level.
TNXP was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-03-20 | Noble Capital Markets | Reiterate | Outperform -> Outperform |
| 2024-07-22 | Alliance Global Partners | Maintains | Buy -> Buy |
| 2024-02-28 | Dawson James | Initiate | Buy |
| 2023-08-01 | Alliance Global Partners | Maintains | Buy -> Buy |
| 2023-06-02 | Alliance Global Partners | Maintains | Buy -> Buy |
| 2023-01-12 | Alliance Global Partners | Reiterate | Buy |
| 2022-04-18 | Noble Capital Markets | Initiate | Outperform |